September 28, 2011 Summary: Raising afib awareness is intensely personal for StopAfib.org founder, Mellanie True Hills, which led her to create Atrial Fibrillation Awareness Month. Dallas, TX — September 2011 is the fifth annual Atrial Fibrillation Awareness Month. Raising afib awareness is intensely personal for StopAfib.org founder, Mellanie True Hills, and led her to create …
Read More
September is Atrial Fibrillation Awareness Month. Lots of folks don’t know too much about the condition, which is an irregular heart beat that can lead to serious complications such as dementia, heart failure, stroke or even death. To help spread the word, StopAfib.org presents 10 afib facts and figures that will probably surprise even some …
Read More
By Mellanie True Hills September is Atrial Fibrillation Awareness Month. Why do we need a month devoted to afib? In my opinion piece, Atrial Fibrillation Month Raises Awareness about this Common, Yet Unknown Condition, I share why I started Atrial Fibrillation Awareness Month four years ago and why I have helped lead this awareness campaign. …
Read More
Cidade do México, 8 de setembro de 2011 – É necessário haver uma medida coordenada urgente por parte de governos nacionais, sociedades médicas e organização de pacientes para evitar uma crise na saúde pública decorrente de uma tendência de derrames passíveis de prevenção que deixam muitos indivíduos com fibrilação atrial (FA) incapacitados mental ou fisicamente …
Read More
Ciudad de México, 8 de septiembre de 2011 – Se necesita acción coordinada urgente de gobiernos nacionales, sociedades médicas y organizaciones de pacientes para evitar una crisis de la salud pública como resultado de la ola de apoplejías evitables que deja a muchas personas que padecen de fibrilación auricular (FA) mental y físicamente discapacitadas o …
Read More
By Jennifer L.W. Fink Summary: An FDA panel voted to recommend approval of rivaroxaban (Xarelto) for stroke prevention in atrial fibrillation. Approximate reading time: 3–5 minutes Adelphi, MD, September 8, 2011 — An FDA panel voted 9-2-1 to recommend approval of rivaroxaban (Xarelto) for reducing the risk of stroke in those with atrial fibrillation (afib). …
Read More
Mexico City, 8 September 2011 – Urgent coordinated action from national governments, medical societies and patient organizations is needed to avoid a public health crisis resulting from the tide of preventable strokes that leave many people with atrial fibrillation (AF) mentally and physically disabled or dead, every year. How Can We Avoid a Stroke Crisis …
Read More
September 7, 2011 Summary: Our September focus is on National Atrial Fibrillation Awareness Month, including US Senate passage of the Atrial Fibrillation Resolution and current afib awareness public service announcements. Reading time: 1–2 minutes By Mellanie True Hills September 7, 2011 Dallas, TX — In our September Patient Perspective column in EP Lab Digest, we …
Read More
By Jennifer L.W. Fink Summary: The drug rivaroxaban was shown to be as good as warfarin for stroke prevention in a large study that was recently published in the New England Journal of Medicine. Approximate reading time: 3–5 minutes September 6, 2011 A New England Journal of Medicine article, Rivaroxaban versus Warfarin in Nonvalvular Atrial …
Read More
September 1, 2011 Summary: A new Atrial Fibrillation in Primary Care (AFIP) Tool can be useful for patients in working with their doctors, especially those with newly-diagnosed atrial fibrillation. Two of the coauthors, Professors John Camm and Gregory Lip, are members of the StopAfib.org Global Medical Advisory Board, and StopAfib.org founder Mellanie True Hills provided …
Read More